Sample characteristics
| Sample | ||||
|---|---|---|---|---|
| All | PPMS | Rehabilitation | Steroids | |
| *Mean (SD); range; †PPMS, SPMS, RRMS: primary progressive, secondary progressive, and relapsing remitting MS, respectively; ‡patient reported. | ||||
| Sample size | 245 | 104 | 64 | 77 |
| Age* | 46.8 (12.0); 17–83 | 52.0 (10.3); 28–73 | 45.3 (11.9); 18–69 | 41.6 (11.4);17–83 |
| No. female (%) | 140 (57.4) | 44 (42.7) | 41 (64.1) | 55 (71.4) |
| Type of MS (%)† | ||||
| PPMS | 117 (51.1) | 104 (100) | 12 (18.8) | 1 (1.3) |
| SPMS | 61 (24.9) | 0 (0) | 40 (62.5) | 21 (27.3) |
| RRMS | 67 (27.3) | 0 (0) | 12 (18.8) | 55 (71.4) |
| Indoor mobility (%) | ||||
| Unaided | 63 (26.0) | 19 (18.8) | 3 (4.7) | 41 (53.2) |
| With aid | 116 (47.9) | 54 (53.5) | 29 (45.3) | 33 (42.9) |
| Wheelchair | 63 (26.0) | 28 (27.7) | 32 (50.0) | 3 (3.9) |
| Duration of MS since diagnosis*‡ | 10.3 (8.3); 0–60 | 9.1 (4.9); 2–23 | 12.3 (10.2); 0–35 | 10.4 (9.7); 1–60 |
| Marital status (%) | ||||
| Single | 43 (17.7) | 17 (16.5) | 11 (17.5) | 15 (19.5) |
| Separated | 2 (0.8) | 0 (0) | 1 (1.6) | 1 (1.3) |
| Married | 152 (62.6) | 70 (68.0) | 41 (65.1) | 41 (53.2) |
| Inpatient stay weeks* | N/A | N/A | 3.67 (1.2); 2–7 | N/A |